Skip to main content
Premium Trial:

Request an Annual Quote

NanoString Raises $30M in Private Financing

NEW YORK (GenomeWeb News) – NanoString Technologies has closed a series C financing round, raising $30 million from venture capital investors.

The Seattle-based firm said the financing was completed through two tranches, and the funds will be used to accelerate commercialization of its nCounter Analysis System for research and diagnostic applications. The system is a digital gene-expression tool that can multiplex hundreds of genes per sample.

The most recent round of financing was led by Clarus Ventures and included existing investors OVP Venture Partners and Draper Fisher Jurvetson. In connection with the investment, Clarus Ventures Co-founder and Managing Director Nicholas Galakatos will join NanoString's board of directors.

"We believe that NanoString Technologies has the best-in-class platform for expression profiling," Galakatos said in a statement. "Their uniquely user-friendly technology that does not require sample purification or use of PCR constitutes a breakthrough in the field."

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.